{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:54:30Z","timestamp":1784152470790,"version":"3.55.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["DNA and Cell Biology"],"published-print":{"date-parts":[[2020,1,30]]},"abstract":"<jats:p>\n                    Hunter's syndrome (mucopolysaccharidosis type II) is a rare X-linked lysosomal storage disorder caused by mutations in the iduronate-2-sulfatase (IDS) gene. Motivated by the case of a child affected by this syndrome, we compared the intracellular fate of wild-type IDS (IDS\n                    <jats:sub>WT<\/jats:sub>\n                    ) and four nonsense mutations of IDS (IDS\n                    <jats:sub>L482X<\/jats:sub>\n                    , IDS\n                    <jats:sub>Y452X<\/jats:sub>\n                    , IDS\n                    <jats:sub>R443X<\/jats:sub>\n                    , and IDS\n                    <jats:sub>W337X<\/jats:sub>\n                    ) generating progressively shorter forms of IDS associated with mild to severe forms of the disease. Our analyses revealed formylation of all forms of IDS at cysteine 84, which is a prerequisite for enzymatic activity. After formylation, IDS\n                    <jats:sub>WT<\/jats:sub>\n                    was transported within lysosomes, where it was processed in the mature form of the enzyme. The length of disease-causing deletions correlated with gravity of the folding and transport phenotype, which was anticipated by molecular dynamics analyses. The shortest form of IDS, IDS\n                    <jats:sub>W337X<\/jats:sub>\n                    , was retained in the endoplasmic reticulum (ER) and degraded by the ubiquitin-proteasome system. IDS\n                    <jats:sub>R443X<\/jats:sub>\n                    , IDS\n                    <jats:sub>Y452X<\/jats:sub>\n                    , and IDS\n                    <jats:sub>L482X<\/jats:sub>\n                    passed ER quality control and were transported to the lysosomes, but failed lysosomal quality control, resulting in their rapid clearance and in loss-of-function phenotype. Failure of ER quality control inspection is an established cause of loss of function observed in protein misfolding diseases. Our data reveal that fulfillment of ER requirements might not be sufficient, highlight lysosomal quality control as the distal station to control lysosomal enzymes fitness and pave the way for alternative therapeutic interventions.\n                  <\/jats:p>","DOI":"10.1089\/dna.2019.5221","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:23:28Z","timestamp":1577967808000},"page":"226-234","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter's Syndrome"],"prefix":"10.1177","volume":"39","author":[{"given":"Alessandro","family":"Marazza","sequence":"first","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."},{"name":"Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Galli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Fasana","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Sgrignani","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricie","family":"Burda","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Stoffwechselkrankheiten, Kinderspital Z\u00fcrich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico M.A.","family":"Fassi","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Baumgartner","sequence":"additional","affiliation":[{"name":"Abteilung f\u00fcr Stoffwechselkrankheiten, Kinderspital Z\u00fcrich, Zurich, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."},{"name":"Swiss Institute of Bioinformatics, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Molinari","sequence":"additional","affiliation":[{"name":"Universit\u00e0 della Svizzera italiana, Lugano, Switzerland."},{"name":"Institute for Research in Biomedicine, Bellinzona, Switzerland."},{"name":"\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne, Lausanne, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1021\/cr040426m","article-title":"Molecular dynamics: survey of methods for simulating the activity of proteins","volume":"106","author":"Adcock S.A.","year":"2006","unstructured":"Adcock S.A., , and McCammon J.A. (2006). Molecular dynamics: survey of methods for simulating the activity of proteins. Chem Rev, 106, 1589\u20131615.","journal-title":"Chem Rev"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00041"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1073\/pnas.70.7.2134","article-title":"The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase","volume":"70","author":"Bach G.","year":"1973","unstructured":"Bach G., , Eisenberg F.Jr., , Cantz M., , and Neufeld E.F. (1973). The defect in the Hunter syndrome: deficiency of sulfoiduronate sulfatase. Proc Natl Acad Sci U S A, 70, 2134\u20132138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2013.08.011","article-title":"Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients","volume":"111","author":"Brusius-Facchin A.C.","year":"2014","unstructured":"Brusius-Facchin A.C., , Schwartz I.V., , Zimmer C., , Ribeiro M.G., , Acosta A.X., , Horovitz D., et al. (2014). Mucopolysaccharidosis type II: identification of 30 novel mutations among Latin American patients. Mol Genet Metab, 111, 133\u2013138.","journal-title":"Mol Genet Metab"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"15786","DOI":"10.1038\/ncomms15786","article-title":"Insights into Hunter syndrome from the structure of iduronate-2-sulfatase","volume":"8","author":"Demydchuk M.","year":"2017","unstructured":"Demydchuk M., , Hill C.H., , Zhou A., , Bunkoczi G., , Stein P.E., , Marchesan D., et al. (2017). Insights into Hunter syndrome from the structure of iduronate-2-sulfatase. Nat Commun, 8, 15786.","journal-title":"Nat Commun"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/emboj\/18.8.2084","article-title":"Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases","volume":"18","author":"Dierks T.","year":"1999","unstructured":"Dierks T., , Lecca M.R., , Schlotterhose P., , Schmidt B., , and von Figura K. (1999). Sequence determinants directing conversion of cysteine to formylglycine in eukaryotic sulfatases. EMBO J, 18, 2084\u20132091.","journal-title":"EMBO J"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1718910115"},{"key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/humu.1169","article-title":"Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: new mutations in the iduronate-2-sulfatase (IDS) gene","volume":"18","author":"Filocamo M.","year":"2001","unstructured":"Filocamo M., , Bonuccelli G., , Corsolini F., , Mazzotti R., , Cusano R., , and Gatti R. (2001). Molecular analysis of 40 Italian patients with mucopolysaccharidosis type II: new mutations in the iduronate-2-sulfatase (IDS) gene. Hum Mutat, 18, 164\u2013165.","journal-title":"Hum Mutat"},{"key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1399-0004.1998.tb02746.x","article-title":"Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients","volume":"53","author":"Froissart R.","year":"1998","unstructured":"Froissart R., , Maire I., , Millat G., , Cudry S., , Birot A.M., , Bonnet V., et al. (1998). Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients. Clin Genet, 53, 362\u2013368.","journal-title":"Clin Genet"},{"issue":"2","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj3090425","article-title":"Processing of iduronate 2-sulphatase in human fibroblasts","volume":"309","author":"Froissart R.","year":"1995","unstructured":"Froissart R., , Millat G., , Mathieu M., , Bozon D., , and Maire I. (1995). Processing of iduronate 2-sulphatase in human fibroblasts. Biochem J, 309 (Pt 2), 425\u2013430.","journal-title":"Biochem J"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b00864"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/003591571701001833"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1063\/1.445869"},{"issue":"2","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"S303","DOI":"10.1007\/s10545-008-0876-z","article-title":"Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome","volume":"31","author":"Keeratichamroen S.","year":"2008","unstructured":"Keeratichamroen S., , Cairns J.R., , Wattanasirichaigoon D., , Wasant P., , Ngiwsara L., , Suwannarat P., et al. (2008). Molecular analysis of the iduronate-2-sulfatase gene in Thai patients with Hunter syndrome. J Inherit Metab Dis, 31 Suppl 2, S303\u2013S311.","journal-title":"J Inherit Metab Dis"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac025747h"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1021\/acs.jcim.6b00305","article-title":"Exploring protein stability by comparative molecular dynamics simulations of homologous hyperthermophilic, mesophilic, and psychrophilic proteins","volume":"56","author":"Khan S.","year":"2016","unstructured":"Khan S., , Farooq U., , and Kurnikova M. (2016). Exploring protein stability by comparative molecular dynamics simulations of homologous hyperthermophilic, mesophilic, and psychrophilic proteins. J Chem Inf Model, 56, 2129\u20132139.","journal-title":"J Chem Inf Model"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ymgme.2016.05.003","article-title":"Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: genetic, pathological, and structural studies on iduronate-2-sulfatase","volume":"118","author":"Kosuga M.","year":"2016","unstructured":"Kosuga M., , Mashima R., , Hirakiyama A., , Fuji N., , Kumagai T., , Seo J.H., et al. (2016). Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: genetic, pathological, and structural studies on iduronate-2-sulfatase. Mol Genet Metab, 118, 190\u2013197.","journal-title":"Mol Genet Metab"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.221739"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0999"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac0341261"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"w14001","DOI":"10.4414\/smw.2014.14001","article-title":"Proteostasis: bad news and good news from the endoplasmic reticulum","volume":"144","author":"Noack J.","year":"2014","unstructured":"Noack J., , Brambilla Pisoni G., , and Molinari M. (2014). Proteostasis: bad news and good news from the endoplasmic reticulum. Swiss Med Wkly, 144, w14001.","journal-title":"Swiss Med Wkly"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/ct100578z"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbrc.2019.04.115","article-title":"Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II","volume":"514","author":"Osaki Y.","year":"2019","unstructured":"Osaki Y., , Matsuhisa K., , Che W., , Kaneko M., , Asada R., , Masaki T., et al. (2019). Calnexin promotes the folding of mutant iduronate 2-sulfatase related to mucopolysaccharidosis type II. Biochem Biophys Res Commun, 514, 217\u2013223.","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41419-018-0871-8","article-title":"Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II","volume":"9","author":"Osaki Y.","year":"2018","unstructured":"Osaki Y., , Saito A., , Kanemoto S., , Kaneko M., , Matsuhisa K., , Asada R., et al. (2018). Shutdown of ER-associated degradation pathway rescues functions of mutant iduronate 2-sulfatase linked to mucopolysaccharidosis type II. Cell Death Dis, 9, 808.","journal-title":"Cell Death Dis"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-cellbio-111315-125334","article-title":"Coping with protein quality control failure","volume":"33","author":"Pilla E.","year":"2017","unstructured":"Pilla E., , Schneider K., , and Bertolotti A. (2017). Coping with protein quality control failure. Annu Rev Cell Dev Biol, 33, 439\u2013465.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0092-8674(95)90314-3","article-title":"A novel amino-acid modification in sulfatases that is defective in multiple sulfatase deficiency","volume":"82","author":"Schmidt B.","year":"1995","unstructured":"Schmidt B., , Selmer T., , Ingendoh A., , and Vonfigura K. (1995). A novel amino-acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell, 82, 271\u2013278.","journal-title":"Cell"},{"key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1399-0004.2011.01641.x","article-title":"Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II","volume":"81","author":"Sohn Y.B.","year":"2012","unstructured":"Sohn Y.B., , Ki C.S., , Kim C.H., , Ko A.R., , Yook Y.J., , Lee S.J., et al. (2012). Identification of 11 novel mutations in 49 Korean patients with mucopolysaccharidosis type II. Clin Genet, 81, 185\u2013190.","journal-title":"Clin Genet"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-013-1358-4"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/humu.1380060206","article-title":"Mucopolysaccharidosis type-II (Hunter-disease)\u2014identification and characterization of 8-point mutations in the iduronate-2-sulfatase gene in Japanese patients","volume":"6","author":"Sukegawa K.","year":"1995","unstructured":"Sukegawa K., , Tomatsu S., , Fukao T., , Iwata H., , Song X.Q., , Yamada Y., et al. (1995). Mucopolysaccharidosis type-II (Hunter-disease)\u2014identification and characterization of 8-point mutations in the iduronate-2-sulfatase gene in Japanese patients. Hum Mutat, 6, 136\u2013143.","journal-title":"Hum Mutat"},{"key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1600-0854.2004.00232.x","article-title":"Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease","volume":"5","author":"Ulloa-Aguirre A.","year":"2004","unstructured":"Ulloa-Aguirre A., , Janovick J.A., , Brothers S.P., , and Conn P.M. (2004). Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease. Traffic, 5, 821\u2013837.","journal-title":"Traffic"},{"key":"e_1_3_4_34_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/adc.79.3.237","article-title":"Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)","volume":"79","author":"Vafiadaki E.","year":"1998","unstructured":"Vafiadaki E., , Cooper A., , Heptinstall L.E., , Hatton C.E., , Thornley M., , and Wraith J.E. (1998). Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease). Arch Dis Child, 79, 237\u2013241.","journal-title":"Arch Dis Child"},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease)","volume":"24","author":"Voznyi Y.V.","year":"2001","unstructured":"Voznyi Y.V., , Keulemans J.L., , and van Diggelen O.P. (2001). A fluorimetric enzyme assay for the diagnosis of MPS II (Hunter disease). J Inherit Metab Dis, 24, 675\u2013680.","journal-title":"J Inherit Metab Dis"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/DDDT.S139601","article-title":"Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future","volume":"11","author":"Whiteman D.A.H.","year":"2017","unstructured":"Whiteman D.A.H., , and Kimura A. (2017). Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future. Drug Des Devel Ther, 11, 2467\u20132480.","journal-title":"Drug Des Devel Ther"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/379466a0"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0635-4"}],"container-title":["DNA and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/dna.2019.5221","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dna.2019.5221","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/dna.2019.5221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:57:44Z","timestamp":1777399064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/dna.2019.5221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1,30]]}},"alternative-id":["10.1089\/dna.2019.5221"],"URL":"https:\/\/doi.org\/10.1089\/dna.2019.5221","relation":{},"ISSN":["1044-5498","1557-7430"],"issn-type":[{"value":"1044-5498","type":"print"},{"value":"1557-7430","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}